ClinicalTrials.gg
RecruitingNCT05591196HARNESSUpdated Nov 4, 2026

Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke

An interventional study of Non-invasive Electrical Spinal Cord Stimulation and Activity Based Rehabilitation in Stroke, Ischemic, Chronic Stroke and Hemorrhagic Stroke, sponsored by University of Washington. Recruiting at 1 site in United States. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by University of Washington · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years 1 month later.
Updated Nov 4, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 480 studies in Ischemic Stroke with a site in United States — 120 open to participants now, 145 under way, 13 of them phase 3. Ischemic Stroke · United States.

Planned enrollment
325th of 364
6 · median 65
Started
2022
with 35 others
No phase
183 of 480
51 open now
Primary completion
2027-12
later than 83 of 144 live
Registered
351st of 480
by date

Among the 480 studies in Ischemic Stroke with a site in United States, this one is the 325th largest by planned enrollment of the 364 interventional ones that give a count, is one of 36 that started in 2022, is one of 183 with no phase, reaches primary completion later than 83 of the 144 other live ones, and was the 351st registered.

Ischemic Stroke

2,629 studies on the registry are indexed under Ischemic Stroke; 983 are open to participants now.

Browse Ischemic Stroke studies →

Open to participants now

120 of the 480 studies in Ischemic Stroke with a site in United States are open now. Recruiting first, the newest first:

115 more — sign in →

All 120 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 668 Ischemic Stroke studies recruiting now, 403 (60%) set no upper age limit and 62 (9%) stop at 75 or younger; 27 take children under 18; 41 take healthy volunteers.

This study: 21 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 480 studies in Ischemic Stroke with a site in United States, or all of them as a file.
02

Study summary

The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.

Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.

The aims of the study are:

  1. to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
  2. to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.
03

Conditions studied

  • Stroke, Ischemic
  • Chronic Stroke
  • Hemorrhagic Stroke

Keywords

  • Chronic ischemic stroke
  • Transcutaneous spinal cord stimulation
  • Activity based rehabilitation
04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
  • At least six months post-stroke
  • Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
  • Medically and neurologically stable, as determined by medical history and documented physical examination
  • For women of , a negative over-the-counter pregnancy test at study entry and willingness to practice adequate during the study
  • Ability to attend sessions three times per week
  • Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
  • Ability to read, comprehend and speak English

Exclusion criteria

Exclusion Criteria:

  • Hemorrhagic stroke
  • History of multiple strokes
  • Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
  • Aphasia or any other deficit in communication that interferes with reasonable study participation
  • Moderate to severe cognitive impairment
  • Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
  • Severe spasticity in the upper limb
  • Taking baclofen more than 30 mg/day
  • Change in baclofen dose within four weeks before enrollment
  • Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
  • Botulinum toxin injection to the upper limb muscles within six months before enrollment
  • Severe joint contractures in the affected hand and arm
  • History of spontaneous seizure that had occurred one month or longer after the stroke
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
6 participants (estimated)

Study arms

  • Active comparator
    Activity Based Rehabilitation

    Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

    Other: Activity Based Rehabilitation

  • Experimental
    Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation

    Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

    Device: Non-invasive Electrical Spinal Cord Stimulation · Other: Activity Based Rehabilitation

Interventions

  • DeviceNon-invasive Electrical Spinal Cord Stimulation

    Electrical stimulation of the spinal cord using surface electrodes

  • OtherActivity Based Rehabilitation

    Exercise therapy targeting paralyzed hand and arm

06

What researchers measure

Primary outcomes

  1. Change from baseline - Fugl-Meyer assessment of the upper limb

    The clinician-administered a stroke-specific, performance-based impairment scale. It assesses movement function, sensation, joint range of motion, and pain. The score ranges from 0 to 66. Higher scores indicate better outcomes.

    Time frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

  2. Change from baseline - Pinch and grip force

    Measurement of hand strengths using a dynamometry.

    Time frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

  3. Change from baseline - Modified Ashworth Scale

    Clinician-administered test for resistance of a joint to passive movement. This scale grades muscle tone/spasticity. The score ranges from 0 to 4. Higher scores indicate worse outcomes.

    Time frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

  4. Change from baseline - Wolf Motor Function Test

    Quantifies upper limb motor ability through timed and functional tasks. The score range is 0-75; higher scores denote better function.

    Time frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

Secondary outcomes

  1. Change from baseline - Action Research Arm Test

    Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery.

    Time frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

  2. Change from baseline - Box and Blocks Test

    Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds. Measures gross manual dexterity.

    Time frame: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."

  3. Change from baseline - Revised Nottingham Sensory Assessment

    A standardized scale for assessing sensory impairment in stroke patients. Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

  4. Change from baseline - Stroke Impact Scale

    A self-report questionnaire that evaluates disability and health-related quality of life after stroke. The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function. The score ranges from 0 to 100. Higher scores indicate better outcomes.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

  5. Change from baseline - Short Form-36

    A self-report health survey questionnaire. The score range from 0 to 100. The higher the score, the better the outcome.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

  6. Change from baseline - Patients Global Impression of Change

    A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

  7. Change from baseline - H-reflex test

    Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

  8. Change from baseline - Somatosensory evoked potentials test

    Electrophysiologic evaluation of sensory pathways between the brain and the limb.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

  9. Change from baseline - Spinally evoked motor potentials test

    Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles.

    Time frame: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."

07

Study locations

1 of 1 sites recruiting
  • University of Washington
    Seattle, Washington 98105, United States
    Recruiting
    • Fatma Inanici, MD, Ph.D. · Contactfinanici@uw.edu · 2067872692
    • Fatma Inanici, MD, PhD · Sub investigator
    • Chet T Moritz, PhD · Principal investigator
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2022 (actual). Primary completion is estimated for Dec 2027, 62 months after the start.

Of 576 non-industry interventional studies with no phase under Ischemic Stroke, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 62 months is above that.

Counting every sponsor, half of 656 studies reached it within 27 months; a quarter within 14 and three quarters within 48.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Jul 2026 → Dec 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2022
First posted
Oct 24, 2022
StartActual
Oct 1, 2022
Primary completionEst.
Dec 31, 2027was Jul 2026
CompletionEst.
Dec 31, 2027was Dec 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 30, 2026→Dec 31, 2027
Nov 4, 2026
Study completion
Dec 31, 2026→Dec 31, 2027
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Primary completion Jul 30, 2026→Dec 31, 2027
    Study completion Dec 31, 2026→Dec 31, 2027
    + 5 other changes: verification date, responsible party, conditions, data sharing statement and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05591196
Responsible party
Chet Moritz (Professor, Electrical and Computer Engineering, Rehabilitation Medicine, University of Washington) — Principal investigator
First posted
Oct 24, 2022
Start date
Oct 1, 2022
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Fatma Inanici
Contact
finanici@uw.edu
206-787-2692
Chet Moritz, PhD
principal investigator · University of Washington

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion